Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Prognosis of patients with sickle cell disease and COVID-19: a French experience.
Arlet JB, de Luna G, Khimoud D, Odièvre MH, de Montalembert M, Joseph L, Chantalat-Auger C, Flamarion E, Bartolucci P, Lionnet F, Monnier S, Guillaumat C, Santin A. Arlet JB, et al. Among authors: guillaumat c. Lancet Haematol. 2020 Sep;7(9):e632-e634. doi: 10.1016/S2352-3026(20)30204-0. Epub 2020 Jun 18. Lancet Haematol. 2020. PMID: 32563282 Free PMC article. No abstract available.
Evaluation of Outcomes and Quality of Care in Children with Sickle Cell Disease Diagnosed by Newborn Screening: A Real-World Nation-Wide Study in France.
Brousse V, Arnaud C, Lesprit E, Quinet B, Odièvre MH, Etienne-Julan M, Guillaumat C, Elana G, Belloy M, Garnier N, Chamouine A, Dumesnil C, Montalembert M, Pondarre C, Bernaudin F, Couque N, Boutin E, Bardakjian J, Djennaoui F, Ithier G, Benkerrou M, Thuret I. Brousse V, et al. Among authors: guillaumat c. J Clin Med. 2019 Oct 2;8(10):1594. doi: 10.3390/jcm8101594. J Clin Med. 2019. PMID: 31581727 Free PMC article.
Appropriate thresholds for accurate screening for β-thalassemias in the newborn period: results from a French center for newborn screening.
Allaf B, Pondarre C, Allali S, De Montalembert M, Arnaud C, Barrey C, Benkerrou M, Benhaim P, Bensaid P, Brousse V, Dollfus C, Eyssette-Guerreau S, Galacteros F, Gajdos V, Garrec N, Guillaumat C, Guitton C, Monfort-Gouraud M, Gouraud F, Holvoet L, Ithier G, Kamdem A, Koehl B, Malric A, Missud F, Monier B, Odièvre MH, Joly P, Renoux C, Patin F, Pissard S, Couque N. Allaf B, et al. Among authors: guillaumat c. Clin Chem Lab Med. 2020 Aug 19;59(1):209-216. doi: 10.1515/cclm-2020-0803. Clin Chem Lab Med. 2020. PMID: 32813673
Severe cases of COVID-19 in children with sickle cell disease during the Omicron wave in France: a plea for vaccination.
Eyssette-Guerreau S, Khimoud D, Michaux K, Odièvre MH, Allali S, Pertuisel S, Guillaumat C, Monfort M, Guitton C, Miquel A, Runel C, Gauthier A, Arlet JB. Eyssette-Guerreau S, et al. Among authors: guillaumat c. Br J Haematol. 2022 Oct;199(2):e8-e11. doi: 10.1111/bjh.18409. Epub 2022 Aug 22. Br J Haematol. 2022. PMID: 35993188 Free PMC article. No abstract available.
Delayed hemolytic transfusion reaction in children with sickle cell disease: first 5-year retrospective study in mainland France.
Falguière C, Allali S, Khazem B, Kamdem A, Arnaud C, Belloy M, Guitton C, Odièvre MH, Pertuisel S, Dumesnil C, Guillaumat C, Garrec N, Gauthier A, Mahe P, Soussan-Banini V, Le-Carrer L, Merlin E, David A, Pellegrino B, Paillard C, Brasme JF, Lagarde M, Pirenne F, Pondarre C. Falguière C, et al. Among authors: guillaumat c. Haematologica. 2023 Mar 1;108(3):889-894. doi: 10.3324/haematol.2022.281050. Haematologica. 2023. PMID: 36325889 Free PMC article. No abstract available.
Childhood immune thrombocytopenia: A nationwide cohort study on condition management and outcomes.
Grimaldi-Bensouda L, Nordon C, Leblanc T, Abenhaim L, Allali S, Armari-Alla C, Berger C, Courcoux MF, Fouyssac F, Guillaumat C, Guitton C, Le Moine P, Mazingue F, Pondarré C, Thomas C, Pasquet M, Perel Y, Leverger G, Aladjidi N. Grimaldi-Bensouda L, et al. Among authors: guillaumat c. Pediatr Blood Cancer. 2017 Jul;64(7). doi: 10.1002/pbc.26389. Epub 2016 Dec 1. Pediatr Blood Cancer. 2017. PMID: 27905681
Decision-tree derivation and external validation of a new clinical decision rule (DISCERN-FN) to predict the risk of severe infection during febrile neutropenia in children treated for cancer.
Delebarre M, Gonzales F, Behal H, Tiphaine A, Sudour-Bonnange H, Lutun A, Abbou S, Pertuisel S, Thouvenin-Doulet S, Pellier I, Mansuy L, Piguet C, Paillard C, Blanc L, Thebaud E, Plantaz D, Blouin P, Schneider P, Guillaumat C, Simon P, Domenech C, Pacquement H, Le Meignen M, Pluchart C, Vérite C, Plat G, Martinot A, Duhamel A, Dubos F. Delebarre M, et al. Among authors: guillaumat c. Lancet Child Adolesc Health. 2022 Apr;6(4):260-268. doi: 10.1016/S2352-4642(21)00337-0. Epub 2021 Dec 3. Lancet Child Adolesc Health. 2022. PMID: 34871572
Varicella post-exposure management for pediatric oncology patients.
Costa G, Orbach D, Saulpic J, Sarda-Thibault H, Hanslik T, Brethon B, Tabone MD, Raimbault S, Papillard S, Guillaumat C, Nathanson S, Pellegrino B, Belloy M, Mesples B, Trioche P, Jaber H, Raimondo G, Gilet C, Cohen-Gogo S. Costa G, et al. Among authors: guillaumat c. Bull Cancer. 2022 Mar;109(3):287-295. doi: 10.1016/j.bulcan.2021.11.016. Epub 2022 Jan 31. Bull Cancer. 2022. PMID: 35093244
13 results